시장보고서 | 연간정보서비스 | 맞춤형시장조사 | 메일링 | 샘플 요청 목록
세계의 만성 통증 치료 시장 보고서(2025년)
Chronic Pain Treatment Global Market Report 2025
상품코드 : 1764284
리서치사 : The Business Research Company
발행일 : On Demand Report
페이지 정보 : 영문 175 Pages
 라이선스 & 가격 (부가세 별도)
US $ 4,490 ￦ 6,650,000
PDF (Single User License) help
PDF 보고서를 1명만 이용할 수 있는 라이선스입니다. 인쇄 가능하며 인쇄물의 이용 범위는 PDF 이용 범위와 동일합니다.
US $ 6,490 ￦ 9,612,000
PDF (Site License) help
PDF 보고서를 동일 사업장의 모든 분이 이용할 수 있는 라이선스입니다. 인쇄 가능하며 인쇄물의 이용 범위는 PDF 이용 범위와 동일합니다.
US $ 8,490 ￦ 12,575,000
PDF (Enterprise License) help
PDF 보고서를 동일 기업의 모든 분이 이용할 수 있는 라이선스입니다. 인쇄 가능하며 인쇄물의 이용 범위는 PDF 이용 범위와 동일합니다.


ㅁ Add-on 가능: 고객의 요청에 따라 일정한 범위 내에서 Customization이 가능합니다. 자세한 사항은 문의해 주시기 바랍니다.
ㅁ 보고서에 따라 최신 정보로 업데이트하여 보내드립니다. 배송기일은 문의해 주시기 바랍니다.

한글목차

만성 통증 치료 시장 규모는 향후 몇 년간 강력한 성장이 예상될 예정입니다. 툴의 채용 확대, 통증 진단 및 치료 계획에 있어서의 AI의 이용 확대 등에 기인한다고 생각됩니다.

관절염 통증의 유병률 상승은 앞으로 수년간의 만성 통증 치료 시장의 성장을 크게 견인할 것으로 예측됩니다. 불쾌감, 통증, 시비레를 특징으로 하며, 세계 인구의 고령화에 따라 점점 보편화되고 있습니다. 연질 질환의 높은 발병률로 이어져 효과적인 만성 통증 관리에 대한 수요가 증가하고 있습니다. 예를 들어, 2023년 3월 영국 정부 부처인 보건 개선 및 격차 사무소는 16세 이상 인구의 17.6%가 2022년에 관절염이나 만성 관절 문제와 같은 장기 근골격계 질환을 앓고 있다고 보고했는데, 이는 2021년 17.0%에서 증가한 수치입니다.

만성 통증 치료 시장에서 사업을 전개하는 주요 기업은 환자의 편의성을 향상시키고 장기적인 통증 관리의 성과를 높이기 위해 충전식 척수 자극 장치와 같은 혁신적인 제품 개발에 주력하고 있습니다. 이식형 의료기기로, 전기 펄스를 공급하여 통증의 신호를 차단합니다. 예를 들어, 미국의 의료기기 제조업체인 Abbott Laboratories는 2022년 12월, 척수 자극 시스템 "에테르나"를 출시했습니다. 이보다 작은 이 장치는 상당한 통증 완화를 제공하고 오피오이드 의존성을 완화시킬 가능성을 보여주며, 낮은 침습으로 장기간 사용하도록 설계되었으며 결국 환자의 일상 기능과 삶의 질을 향상시킵니다.

목차

제1장 주요 요약

제2장 시장 특징

제3장 시장 동향과 전략

제4장 시장 : 금리, 인플레이션, 지정학, 무역전쟁과 관세, 코로나 및 회복이 시장에 미치는 영향을 포함한 거시경제 시나리오

제5장 세계의 성장 분석과 전략 분석 프레임워크

제6장 시장 세분화

제7장 지역별/국가별 분석

제8장 아시아태평양 시장

제9장 중국 시장

제10장 인도 시장

제11장 일본 시장

제12장 호주 시장

제13장 인도네시아 시장

제14장 한국 시장

제15장 서유럽 시장

제16장 영국 시장

제17장 독일 시장

제18장 프랑스 시장

제19장 이탈리아 시장

제20장 스페인 시장

제21장 동유럽 시장

제22장 러시아 시장

제23장 북미 시장

제24장 미국 시장

제25장 캐나다 시장

제26장 남미 시장

제27장 브라질 시장

제28장 중동 시장

제29장 아프리카 시장

제30장 경쟁 구도와 기업 프로파일

제31장 기타 주요 기업 및 혁신 기업

제32장 세계 시장 경쟁 벤치마킹과 대시보드

제33장 주요 인수합병(M&A)

제34장 최근 시장 동향

제35장 시장의 잠재력이 높은 국가, 전략

제36장 부록

KTH
영문 목차

영문목차

Chronic pain treatment involves ongoing management of pain lasting longer than three months, often extending beyond normal healing time. It typically combines medications, physical therapy, psychological support, and lifestyle modifications to reduce pain severity, improve functional abilities, and enhance overall quality of life.

The primary product types in chronic pain treatment include drugs and devices. Drugs for chronic pain work by targeting inflammation, nerve signaling, or underlying causes to alleviate persistent pain and improve patient outcomes. These medications address a variety of conditions such as neuropathic pain, arthritis, chronic back pain, cancer-related pain, migraine, fibromyalgia, and more. They are distributed through multiple channels, including both direct and indirect methods, and are utilized by a diverse set of end users including hospitals, clinics, nursing homes, research institutions, and universities.

The chronic pain treatment market research report is one of a series of new reports from The Business Research Company that provides chronic pain treatment market statistics, including the chronic pain treatment industry global market size, regional shares, competitors with the chronic pain treatment market share, detailed chronic pain treatment market segments, market trends, and opportunities, and any further data you may need to thrive in the chronic pain treatment industry. These chronic pain treatment market research report delivers a complete perspective of everything you need, with an in-depth analysis of the current and future scenarios of the industry.

The chronic pain treatment market size has grown strongly in recent years. It will grow from $99.64 billion in 2024 to $109.05 billion in 2025 at a compound annual growth rate (CAGR) of 9.4%. The growth in the historic period can be attributed to the aging population, increasing prevalence of chronic diseases, heightened awareness of pain management, growth in prescription opioid use, and expansion of health insurance coverage.

The chronic pain treatment market size is expected to see strong growth in the next few years. It will grow to $155.00 billion in 2029 at a compound annual growth rate (CAGR) of 9.2%. The growth in the forecast period can be attributed to a shift toward non-opioid alternatives, increased government funding for pain research, rising demand for personalized medicine, growing adoption of digital pain management tools, and expanding use of AI in pain diagnosis and treatment planning. Major trends during this period include advancements in neuromodulation therapies, integration of telemedicine into pain care, development of cannabinoid-based treatments, emphasis on multidisciplinary treatment approaches, and the rise of wearable pain monitoring devices.

The rising prevalence of arthritis pain is expected to significantly drive the growth of the chronic pain treatment market in the coming years. Arthritis pain, characterized by discomfort, aching, or soreness in the joints due to inflammation or degeneration, is increasingly common as the global population ages. The natural wear and tear on joints over time leads to a higher incidence of arthritis-related conditions, thereby increasing the demand for effective chronic pain management. Treatments targeting inflammation and nerve sensitivity help reduce pain, improve joint function, and enhance the quality of life for those suffering from persistent arthritis symptoms. For example, in March 2023, the Office for Health Improvement and Disparities, a UK government department, reported that 17.6% of individuals aged 16 and older had a long-term musculoskeletal condition, such as arthritis or chronic joint problems, in 2022-an increase from 17.0% in 2021. Consequently, this growing prevalence is a key factor propelling the chronic pain treatment market forward.

Major companies operating in the chronic pain treatment market are focusing on developing innovative products like rechargeable spinal cord stimulators to improve patient convenience and enhance long-term pain management outcomes. A rechargeable spinal cord stimulator is an implantable medical device placed near the spine that delivers electrical pulses to disrupt pain signals, with the added benefit of being externally rechargeable, eliminating the need for additional surgeries. This technology helps manage chronic pain by blocking pain pathways in the spinal cord, thus reducing pain perception in patients suffering from conditions such as failed back surgery syndrome and neuropathic pain. For example, in December 2022, Abbott Laboratories, a US-based medical device company, launched the Eterna spinal cord stimulation system. Compact and discreet-smaller than an Apple AirPods case-this device offers significant pain relief, has shown potential in reducing opioid dependence, and is designed for minimally invasive, long-term use, ultimately improving patients' daily functioning and quality of life.

In May 2025, electroCore Inc., a US-based bioelectronic technology company, acquired NeuroMetrix Inc. for an undisclosed amount. Through this acquisition, electroCore aims to bolster its leadership in the non-invasive bioelectronic therapy market by integrating NeuroMetrix's Quell platform, thereby expanding its product portfolio and accelerating growth in the chronic pain and wellness sectors-especially within the Veterans Affairs (VA) Hospital System. NeuroMetrix Inc., based in the US, specializes in developing non-invasive therapeutic devices targeting chronic pain conditions like fibromyalgia.

Major players in the chronic pain treatment market are Pfizer Inc., Merck & Co. Inc., AbbVie Inc., Bayer AG, Sanofi S.A., Bristol-Myers Squibb Company, AstraZeneca plc, Abbott Laboratories, Novartis AG, GlaxoSmithKline plc, Medtronic plc, Eli Lilly and Company, Teva Pharmaceutical Industries Ltd., Boehringer Ingelheim International GmbH, Boston Scientific Corporation, Bausch Health Companies Inc., Sun Pharmaceutical Industries Ltd., Amneal Pharmaceuticals LLC, Mallinckrodt plc, and Nevro Corp.

North America was the largest region in the chronic pain treatment market in 2024. Asia-Pacific is expected to be the fastest-growing region in the forecast period. The regions covered in chronic pain treatment report are Asia-Pacific, Western Europe, Eastern Europe, North America, South America, Middle East and Africa.

The countries covered in the chronic pain treatment market report are Australia, Brazil, China, France, Germany, India, Indonesia, Japan, Russia, South Korea, UK, USA, Canada, Italy, Spain.

The chronic pain treatment market consists of revenues earned by entities by providing services such as pharmacological treatment, physical therapy, psychological counseling, interventional pain management, alternative therapies, pain management clinics, and telehealth services. The market value includes the value of related goods sold by the service provider or included within the service offering. The chronic pain treatment market also includes sales of lyrica, cymbalta, oxycontin, neurontin, voltaren gel, quell, and precision spectra spinal cord stimulator. Values in this market are 'factory gate' values, that is the value of goods sold by the manufacturers or creators of the goods, whether to other entities (including downstream manufacturers, wholesalers, distributors and retailers) or directly to end customers. The value of goods in this market includes related services sold by the creators of the goods.

The market value is defined as the revenues that enterprises gain from the sale of goods and/or services within the specified market and geography through sales, grants, or donations in terms of the currency (in USD, unless otherwise specified).

The revenues for a specified geography are consumption values that are revenues generated by organizations in the specified geography within the market, irrespective of where they are produced. It does not include revenues from resales along the supply chain, either further along the supply chain or as part of other products.

Chronic Pain Treatment Global Market Report 2025 from The Business Research Company provides strategists, marketers and senior management with the critical information they need to assess the market.

This report focuses on chronic pain treatment market which is experiencing strong growth. The report gives a guide to the trends which will be shaping the market over the next ten years and beyond.

Reasons to Purchase

Where is the largest and fastest growing market for chronic pain treatment ? How does the market relate to the overall economy, demography and other similar markets? What forces will shape the market going forward? The chronic pain treatment market global report from the Business Research Company answers all these questions and many more.

The report covers market characteristics, size and growth, segmentation, regional and country breakdowns, competitive landscape, market shares, trends and strategies for this market. It traces the market's historic and forecast market growth by geography.

The forecasts are made after considering the major factors currently impacting the market. These include the Russia-Ukraine war, rising inflation, higher interest rates, and the legacy of the COVID-19 pandemic.

Scope

Table of Contents

1. Executive Summary

2. Chronic Pain Treatment Market Characteristics

3. Chronic Pain Treatment Market Trends And Strategies

4. Chronic Pain Treatment Market - Macro Economic Scenario Including The Impact Of Interest Rates, Inflation, Geopolitics, Trade Wars and Tariffs, And Covid And Recovery On The Market

5. Global Chronic Pain Treatment Growth Analysis And Strategic Analysis Framework

6. Chronic Pain Treatment Market Segmentation

7. Chronic Pain Treatment Market Regional And Country Analysis

8. Asia-Pacific Chronic Pain Treatment Market

9. China Chronic Pain Treatment Market

10. India Chronic Pain Treatment Market

11. Japan Chronic Pain Treatment Market

12. Australia Chronic Pain Treatment Market

13. Indonesia Chronic Pain Treatment Market

14. South Korea Chronic Pain Treatment Market

15. Western Europe Chronic Pain Treatment Market

16. UK Chronic Pain Treatment Market

17. Germany Chronic Pain Treatment Market

18. France Chronic Pain Treatment Market

19. Italy Chronic Pain Treatment Market

20. Spain Chronic Pain Treatment Market

21. Eastern Europe Chronic Pain Treatment Market

22. Russia Chronic Pain Treatment Market

23. North America Chronic Pain Treatment Market

24. USA Chronic Pain Treatment Market

25. Canada Chronic Pain Treatment Market

26. South America Chronic Pain Treatment Market

27. Brazil Chronic Pain Treatment Market

28. Middle East Chronic Pain Treatment Market

29. Africa Chronic Pain Treatment Market

30. Chronic Pain Treatment Market Competitive Landscape And Company Profiles

31. Chronic Pain Treatment Market Other Major And Innovative Companies

32. Global Chronic Pain Treatment Market Competitive Benchmarking And Dashboard

33. Key Mergers And Acquisitions In The Chronic Pain Treatment Market

34. Recent Developments In The Chronic Pain Treatment Market

35. Chronic Pain Treatment Market High Potential Countries, Segments and Strategies

36. Appendix

(주)글로벌인포메이션 02-2025-2992 kr-info@giikorea.co.kr
ⓒ Copyright Global Information, Inc. All rights reserved.
PC버전 보기